References
- Blumenthal M. Top-selling herbs in the United States. Herbal Medicine: expanded Commission E monographs. Integrative Medicine Communications, Newton, MA 2000; 475
- Astin J A. Why patients use alternative medicine: Results of a national study. JAMA 1998; 279: 1548–53
- Eisenberg D M, Kessler R C, Foster C, et al. Unconventional medicine in the United States: Prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246–52
- Eisenberg D M, Davis R B, Ettner S L, et al. Trends in alternative medicine use in the United States, 1990–1997. Results of a follow-up national survey. JAMA 1998; 280: 1569–75
- Miller L G. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158: 2200–11
- Ernst E, Rand J I, Barnes J, Stevinson C. Adverse effects profile on the herbal antidepressant St. John’s wort (Hypericum perforatum L.). Eur J Clin Pharmacol 1998; 54: 589–94
- Gordon J B. SSRIs and St. John’s wort: Possible toxicity?. Am Fam Physician 1998; 57: 950–1
- DeMott K. St John’s wort tied to serotonin syndrome. Clin Psychiatry 1998; 26: 28
- Mason B J, Blackburn K H. Possible serotonin syndrome associated with tra-madol and sertraline coadministration. Ann Pharmacother 1997; 31: 175–7
- Hernandez A F, Montero N, Pla A, Villaneuva E. Fatal moclobemide overdose or death caused by serotonin syndrome. J Forensic Sci 1995; 40: 128–30
- Nebel A, Schneider B J, Baker R K, Kroll D J. Potential metabolic interaction between St. John’s wort and theophylline. Ann Pharmacother 1999; 33: 502
- Bertilsson L, Carrillo J A, Dahl J L, Llrenena A, Alm C, Bondesson U, Lindstrom L, de la Rubia I R, Ramos S, Benitez J. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmac 1994; 38: 471–73
- Muller W EG, Rossol R. Effects of hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994; 7(suppl 1)S63–64
- Laakman G A, Dienel Mieser M. Clinical significance of hyperforin for the efficacy of hypericum extracts on depressive disorders of different severities. Phyto-medicine 1998; 5: 435–42
- Brockmoller J, Reum T, Bauer S, Kerb R, Hubner W D, Roots I. Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans. Phar-macopsychiat 1997; 30(Suppl)94–101
- Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. Phar-macokinetic interaction of digoxin with an herbal extract from St. John’s wort (Hy-pericum perforatum). Clin Pharmacol Ther 1999; 66: 338–45
- Greiner B, Eichelbaum M, Fritz P, Kreichgauer H P, von Richter O, Zundler J, Kroemer H K. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 1999; 104: 147–53
- Moses E L, Mallinger A G. St. John’s wort: three cases of possible mania induction. J Clin Psychopharmacol 2000; 20: 115–17
- Vorbach E U, Hubner W D, Arnoldt K H. Effectiveness and tolerance of hyper-icum extract LI 160 in comparison with imipramine: Randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol 1994; 7(Suppl 1)S19–23
- Lenoir S, Degenring F H, Saller R. A double-blind randomized trial to investigate three different concentrations of a standardized fresh plant extract obtained from the shoot tips of Hypericum perforatum L. Phytomedicine 1999; 6: 141–46
- Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart K. St. John’s wort for depression an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253–8
- Howland R H. Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996; 16: 425–27
- Bunney W E, Wehr T R, Gillin J C, Post R M, Goodwin F K, vanKamen D P. The switch process in manic-depressive psychosis. Ann Intern Med 1977; 87: 319–35
- Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164: 549–50
- Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H. Inhibition of monoamine oxidase by hypericin. Planta Medica 1984; 50: 272–74
- Demisch L, Holzl J, Gollnik B, Kaczmarczyk P. Identification of selective MAO-Type A inhibitors in Hypericum performatum L. (HyperforatR). Pharmacop-sychiat 1989; 22: 194
- Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of hyper-icum extract. J Geriatr Psychiatry Neurol 1994; 7(Suppl 1)S57–59
- Thiede H M, Walper A. Inhibition of MAO and COMT by hypericum extracts and hypericin. J Geriatr Psychiatry Neurol 1994; 7(Suppl 1)354–56
- Muller W EG, Rossol R. Effects of hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994; 7(Suppl 1)S63–64
- Wiegand D. Piroxicam-induced photosensitivity. J Am Acad Dermatol 1985; 12: 373–74
- Kochevar I, Morison W L, Lamm J L, McAuliffe D J, Western A, Hood A F. Possible mechanism of piroxicam-induced photosensitivty. Arch Dermatol 1986; 122: 1283–87
- Gulick R, Lui H, Anderson R, Lollias N, Hussey N, Crumpacker C. Human hypericism. A photosensitivity reactionto hypericin (St. John’s wort). Internation Conference on AIDS, The Netherlands, 1992
- Araya O S, Ford E JH. An investigation of the type of photosensitization caused by the ingestion of St. John’s wort (Hypericum perforatum) by calves. J Comp Path 1981; 91: 135–141
- Kako M DN, Alsultan I I, Saleem A N. Studies of sheep experimentally poisoned with Hypericum perforatum. Vet Hum Toxicol 1993; 35: 298–300
- Potter T S, Hashimoto K. Cutaneous photosensitivity to medications. Compre-hen Ther 1994; 20: 414–17
- Gould J W, Mercurio M G, Elmets C A. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995; 33: 551–73
- Vassileva S G, Mateev G, Parish L C. Antimicrobial photosensitive reactions. Arch Intern Med 1998; 158: 1993–2000
- Harth Y, Rapoport M. Photosensitivity associated with antipsychotics, antide-pressants and anxiolytics. Drug Safe 1996; 14: 252–9
- Chung K T, Wong T Y, Wei C I, Huang Y W, Lin Y. Tannins and human health: A review. Crit Rev Food Sci Nutrition 1998; 38: 421–64
- Pizarro F, Olivares M, Hertrampf E, Walter T. Factors which modify the nutritional state of iron: Tannin content of herbal teas. Arch Latinoam Nutr 1994; 44: 277–80
- Merhav H, Amitai Y, Palti H. Tea drinking and microcytic anemia in infants. Am J Clin Nutrition 1985; 41: 1210–13
- Koren G, Boichis H, Keren G. Effects of tea on the absorption of pharmacological doses of an oral iron preparation. Sci Meet Israel 1982; 18: 547
- Piscitelli S C, Burstein A H, Chaitt D, Alfaro R M, Falloon J. Indinavir concentrations and St. John’s wort. Lancet 2000; 355: 547–48
- Clevenbergh P, Durant J, Chaillou S, Dellamonica P. HIV drug resistance and insufficient drug plasma levels as factors determining antiretroviral treatment failure. AIDS Rev 1999; 1: 156–66
- Ruschitzka F, Meier P J, Turina M, Luscher T F, Noll G. Acute heart transplant rejection due to Saint John’s wort. Lancet 2000; 355: 548–9